Renovaro
@renovaro.bsky.social
Harnessing AI to improve outcomes for cancer and neurology patients, from screening to diagnosis to treatment.
Find out more on our website (https://www.renovarogroup.com) and our LinkedIn page (https://www.linkedin.com/company/renovaro-biosciences-inc).
Find out more on our website (https://www.renovarogroup.com) and our LinkedIn page (https://www.linkedin.com/company/renovaro-biosciences-inc).
Renovaro just published landmark preclinical data in Vaccines! Our next-gen dendritic cell therapy reduced pancreatic tumour volume by up to 81.7% in humanized mice and activated strong, targeted immune responses. 🧵
#Immunotherapy #CancerResearch #BioTech
#Immunotherapy #CancerResearch #BioTech
July 18, 2025 at 4:02 PM
Renovaro just published landmark preclinical data in Vaccines! Our next-gen dendritic cell therapy reduced pancreatic tumour volume by up to 81.7% in humanized mice and activated strong, targeted immune responses. 🧵
#Immunotherapy #CancerResearch #BioTech
#Immunotherapy #CancerResearch #BioTech
BioSymetrics, a Renovaro company, just secured a key U.S. patent advancing AI-driven drug discovery. Our new methods unify diverse biomedical data for real-time, scalable predictive analytics – a major leap for precision medicine.
#AI #DrugDiscovery #PrecisionMedicine
#AI #DrugDiscovery #PrecisionMedicine
June 4, 2025 at 3:17 PM
BioSymetrics, a Renovaro company, just secured a key U.S. patent advancing AI-driven drug discovery. Our new methods unify diverse biomedical data for real-time, scalable predictive analytics – a major leap for precision medicine.
#AI #DrugDiscovery #PrecisionMedicine
#AI #DrugDiscovery #PrecisionMedicine
Hello Bluesky! We’re Renovaro, using AI-based precision medicine to improve outcomes in oncology and neurology. Our full-stack Bio-AI platform brings together diagnostics, drug discovery, analytics, and validation for faster, more personalized care.
May 21, 2025 at 8:08 PM
Hello Bluesky! We’re Renovaro, using AI-based precision medicine to improve outcomes in oncology and neurology. Our full-stack Bio-AI platform brings together diagnostics, drug discovery, analytics, and validation for faster, more personalized care.